Annual Accounts Payable
$1.46 M
+$961.00 K+192.97%
December 1, 2023
Summary
- As of February 10, 2025, NRSN annual accounts payable is $1.46 million, with the most recent change of +$961.00 thousand (+192.97%) on December 1, 2023.
- During the last 3 years, NRSN annual accounts payable has risen by +$1.40 million (+2552.73%).
- NRSN annual accounts payable is now at all-time high.
Performance
NRSN Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.39 M
-$91.00 K-6.14%
September 1, 2024
Summary
- As of February 10, 2025, NRSN quarterly accounts payable is $1.39 million, with the most recent change of -$91.00 thousand (-6.14%) on September 1, 2024.
- Over the past year, NRSN quarterly accounts payable has dropped by -$992.00 thousand (-41.61%).
- NRSN quarterly accounts payable is now -41.61% below its all-time high of $2.38 million, reached on March 1, 2024.
Performance
NRSN Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
NRSN Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +193.0% | -41.6% |
| 3 y3 years | +2552.7% | +1060.0% |
| 5 y5 years | +6243.5% | - |
NRSN Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +3641.0% | -41.6% | +3469.2% |
| 5 y | 5-year | at high | +6243.5% | -41.6% | >+9999.0% |
| alltime | all time | at high | +6243.5% | -41.6% | >+9999.0% |
NeuroSense Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.39 M(-6.1%) |
| Jun 2024 | - | $1.48 M(-37.8%) |
| Mar 2024 | - | $2.38 M(+63.4%) |
| Dec 2023 | $1.46 M(+193.0%) | $1.46 M(+59.8%) |
| Sep 2023 | - | $913.00 K(-16.2%) |
| Jun 2023 | - | $1.09 M(+160.1%) |
| Mar 2023 | - | $419.00 K(-15.9%) |
| Dec 2022 | $498.00 K | $498.00 K(+141.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $206.00 K(+71.7%) |
| Jun 2022 | - | $120.00 K(-33.3%) |
| Mar 2022 | - | $180.00 K(+361.5%) |
| Dec 2021 | $39.00 K(-29.1%) | - |
| Dec 2021 | - | $39.00 K(+225.0%) |
| Jun 2021 | - | $12.00 K(-78.2%) |
| Dec 2020 | $55.00 K(+139.1%) | $55.00 K |
| Dec 2019 | $23.00 K | - |
FAQ
- What is NeuroSense Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics annual accounts payable year-on-year change?
- What is NeuroSense Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics quarterly accounts payable year-on-year change?
What is NeuroSense Therapeutics annual accounts payable?
The current annual accounts payable of NRSN is $1.46 M
What is the all time high annual accounts payable for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high annual accounts payable is $1.46 M
What is NeuroSense Therapeutics annual accounts payable year-on-year change?
Over the past year, NRSN annual accounts payable has changed by +$961.00 K (+192.97%)
What is NeuroSense Therapeutics quarterly accounts payable?
The current quarterly accounts payable of NRSN is $1.39 M
What is the all time high quarterly accounts payable for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high quarterly accounts payable is $2.38 M
What is NeuroSense Therapeutics quarterly accounts payable year-on-year change?
Over the past year, NRSN quarterly accounts payable has changed by -$992.00 K (-41.61%)